SPONSOR
German University in Cairo
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Rheumatoid Arthritis (RA)
German University in Cairo is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Rheumatoid Arthritis (RA).
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — German University in Cairo
How many clinical trials has German University in Cairo sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by German University in Cairo, of which 1 are actively recruiting participants. These trials cover conditions including Rheumatoid Arthritis (RA). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does German University in Cairo research focus on?
German University in Cairo clinical trials span Rheumatoid Arthritis (RA). The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a German University in Cairo clinical trial?
To participate in a German University in Cairo trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all German University in Cairo trials with current recruitment status updated daily.
Clinical Trials by German University in Cairo
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology